Processa Pharmaceuticals Statistics

Total Valuation

PCSA has a market cap or net worth of $1.26 million. The enterprise value is -$1.59 million.

Market Cap	1.26M
Enterprise Value	-1.59M

Important Dates

The next estimated earnings date is Tuesday, May 20, 2025, after market close.

Earnings Date	May 20, 2025
Ex-Dividend Date	n/a

Share Statistics

PCSA has 5.27 million shares outstanding. The number of shares has increased by 193.57% in one year.

Current Share Class	5.27M
Shares Outstanding	5.27M
Shares Change (YoY)	+193.57%
Shares Change (QoQ)	+171.43%
Owned by Insiders (%)	8.71%
Owned by Institutions (%)	1.88%
Float	4.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.36
P/TBV Ratio	0.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.01.

Current Ratio	2.93
Quick Ratio	2.26
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -192.72% and return on invested capital (ROIC) is -119.93%.

Return on Equity (ROE)	-192.72%
Return on Assets (ROA)	-102.42%
Return on Invested Capital (ROIC)	-119.93%
Return on Capital Employed (ROCE)	-342.78%
Revenue Per Employee	n/a
Profits Per Employee	-$1.20M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.57% in the last 52 weeks. The beta is 1.35, so PCSA's price volatility has been higher than the market average.

Beta (5Y)	1.35
52-Week Price Change	-88.57%
50-Day Moving Average	0.34
200-Day Moving Average	0.93
Relative Strength Index (RSI)	40.36
Average Volume (20 Days)	4,230,478

Short Selling Information

The latest short interest is 70,227, so 1.33% of the outstanding shares have been sold short.

Short Interest	70,227
Short Previous Month	2.01M
Short % of Shares Out	1.33%
Short % of Float	1.52%
Short Ratio (days to cover)	0.39

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.09M
Pretax Income	-9.83M
Net Income	-11.96M
EBITDA	-12.09M
EBIT	-12.09M
Earnings Per Share (EPS)	-$2.48

Full Income Statement

Balance Sheet

The company has $2.90 million in cash and $49,659 in debt, giving a net cash position of $2.85 million or $0.54 per share.

Cash & Cash Equivalents	2.90M
Total Debt	49,659
Net Cash	2.85M
Net Cash Per Share	$0.54
Equity (Book Value)	3.53M
Book Value Per Share	0.67
Working Capital	2.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.93 million and capital expenditures -$3,244, giving a free cash flow of -$11.93 million.

Operating Cash Flow	-11.93M
Capital Expenditures	-3,244
Free Cash Flow	-11.93M
FCF Per Share	-$2.26

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PCSA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-193.57%
Shareholder Yield	-193.57%
Earnings Yield	-950.34%
FCF Yield	-948.05%

Analyst Forecast

The average price target for PCSA is $6.00, which is 2,412.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	2,412.56%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 22, 2024. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Jan 22, 2024
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1